Business Wire

NY-LINEAGE-LOGISTICS

23.3.2020 21:09:09 CET | Business Wire | Press release

Share
Kyrie Irving Invites Fans To Share A Meal With Lineage Logistics In Support Of Those Affected By COVID-19 Pandemic

Kyrie Irving has partnered with Lineage Logistics , the world’s largest and most innovative provider of temperature-controlled logistics, and Feeding America® , the nation’s largest hunger-relief organization, to raise awareness for its Share A Meal campaign, which aims to help provide 100 million meals* in response to COVID-19. The campaign goal is to help ensure no family or child goes hungry during this global pandemic.

Kyrie is personally contributing $323,000, and is asking his family, friends, fans and partners to join him in donating in support of Feeding America’s COVID-19 Response Fund. Lineage Logistics will match all donations up to $200,000 to City Harvest, New York City’s private response to hunger and largest food rescue organization, and in addition, Kyrie and Lineage are donating over 250,000 meals** to City Harvest to immediately help those affected by COVID-19.

“Seeing the effects of COVID-19 reach our families, our schools, our jobs, and access to food has really impacted me,” said Kyrie. “I am excited to partner with Feeding America and Lineage Logistics to launch the Share A Meal campaign to help marginalized communities get the food resources they require during this time, and to work with City Harvest to distribute meals to my neighbors in need across the New York area. Thank you to everyone on the front line working to keep all of us safe, healthy, and fed. Together we can change the world one small gesture at a time."

“The COVID-19 virus presents extraordinary challenges for moving, storing, and distributing food on a large scale,” said Greg Lehmkuhl, Lineage’s President & CEO. “At Lineage, we’ve built a business dedicated to shepherding food all over the world, and that experience puts us in a unique position to help overcome these challenges. We want to do our part by sharing what we have to offer – including temperature-controlled warehouse space, supply chain logistics expertise and financial resources.”

City Harvest is dedicated to feeding New Yorkers who are struggling to put meals on their tables, and in response to the COVID-19 crisis and its devastating economic impact, the organization is stepping up to rescue and deliver more food to meet the increasing need. Deemed an essential service by Governor Cuomo and New York State, its fleet of 22 trucks will continue to be on the road, working hard to make sure all children, families, and New Yorkers in need have enough nutritious food in the coming weeks, months, and beyond.

Lineage is working with a variety of strategic partners, including Kyrie and Stephen and Ayesha Curry’s foundation, Eat. Learn. Play., to achieve its campaign goal of 100 million meals. Recognizing that COVID-19 is a worldwide crisis, Lineage is working with the Global FoodBanking Network , to provide funds, donate food, and volunteer the company’s storage resources and distribution expertise on a global scale. The Company will also leverage its expansive network of customers, which includes some of the world’s largest food producers and manufacturers, to join Lineage in its commitment to reach Share A Meal ’s ambitious goal.

To join the Share A Meal effort and support Feeding America and City Harvest, please visit http://feedingamerica.org/kyrie-covid .

*100 million meal equivalent will include financial and in-kind donations facilitated by Lineage and its partners to Feeding America and other hunger-relief organizations.

**The 250,000 meal donation is equivalent to 25,000 pounds of food being donated to City Harvest as well as a $25,000 monetary donation, according to the following calculation: $1 = 10 meals.

About Lineage Logistics

Lineage is the world’s largest and most innovative provider of temperature-controlled logistics solutions. Lineage’s expertise in end-to-end logistical solutions, its unrivaled facility network, and its use of technology combine to promote food safety, increase distribution efficiency, advance sustainability, lessen environmental impact, and minimize supply chain waste. As a result, Lineage helps customers ranging from Fortune 500 companies to small family-owned businesses increase the efficiency and protect the integrity of their temperature-controlled supply chain. In recognition of the company’s leading innovations, Lineage was recognized as the No 1. Data Science company on Fast Company’s Annual list of The World’s Most Innovative Companies in 2019, in addition to ranking 23rd overall in an evaluation of thousands of companies worldwide. For more information, visit: www.lineagelogistics.com .

About City Harvest

City Harvest is New York City’s largest food rescue organization, helping to feed the nearly 1.2 million New Yorkers who are struggling to put meals on their tables. We will rescue 66 million pounds of food this year and deliver it, free of charge, to hundreds of soup kitchens, food pantries, and other community partners across the five boroughs. Our programs empower individuals through nutrition education, increase our partners’ capacity, and strengthen the local food system, helping New Yorkers who are experiencing food insecurity to access, afford, and consume nutritious food. To learn more about our work, visit www.cityharvest.org

About Feeding America®

Feeding America® is the largest hunger-relief organization in the United States. Through a network of 200 food banks and 60,000 food pantries and meal programs, we provide meals to more than 40 million people each year. Feeding America also supports programs that prevent food waste and improve food security among the people we serve; educates the public about the problem of hunger; and advocates for legislation that protects people from going hungry. Individuals, charities, businesses and government all have a role in ending hunger. Donate. Volunteer. Advocate. Educate. Together we can solve hunger. Visit www.feedingamerica.org , find us on Facebook or follow us on Twitter .

Link:

ClickThru

Social Media:

https://www.facebook.com/lineagelogistics/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye